Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modification of Cue Reactivity by Neurofeedback in Human Addiction

NCT04366505 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04366505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modification of Cue Reactivity by Neurofeedback in Human Addiction
Lead sponsor
Central Institute of Mental Health, Mannheim
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2021
Completion date
June 30, 2023
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)